Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Comparison of Abbott Architect ® , Siemens Immulite ® , and Diasorin Liaison ® for determination of Epstein–Barr virus serological diagnosis

(2018) Catherine François et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis

(2017) René M. Gieß et al.   PLoS One

Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016

(2017) Grégoire Fourcade et al.   PLoS One

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update

(2016) Kassandra Munger et al.   SEMINARS IN NEUROLOGY

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

(2015) Lazaros Belbasis et al.   LANCET NEUROLOGY

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

(2015) J Kuhle et al.   Multiple Sclerosis Journal

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

(2015) J Kuhle et al.   Multiple Sclerosis Journal

Performance of the Architect EBV Antibody Panel for Determination of Epstein-Barr Virus Infection Stage in Immunocompetent Adolescents and Young Adults with Clinical Suspicion of Infectious Mononucleosis

(2014) Alvaro Guerrero-Ramos et al.   Clinical and Vaccine Immunology

Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition

(2013) Henry H. Balfour et al.   JOURNAL OF INFECTIOUS DISEASES

Are there Epstein–Barr virus seronegative patients with multiple sclerosis?

(2013) Katrin Deuschle et al.   Multiple Sclerosis Journal

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study

(2013) Dana Horakova et al.   PLoS One

Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis

(2013) Yahya H. Almohmeed et al.   PLoS One

Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students

(2012) Henry H. Balfour et al.   JOURNAL OF INFECTIOUS DISEASES

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

(2012) J. Pakpoor et al.   Multiple Sclerosis Journal

The initiation and prevention of multiple sclerosis

(2012) Alberto Ascherio et al.   Nature Reviews Neurology

Primary infection with the epstein-barr virus and risk of multiple sclerosis

(2010) Lynn I. Levin et al.   ANNALS OF NEUROLOGY

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis

(2010) Adam E. Handel et al.   PLoS One

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis

(2009) Douglas S. Goodin   PLoS One

Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern

(2008) Massimo De Paschale et al.   JOURNAL OF MEDICAL VIROLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET